RecruitingNCT05186636

Dialyzing Wisely - Improving the Delivery of Acute Renal Replacement Therapy to Albertans

Sponsor

University of Alberta

Enrollment

4,500 participants

Start Date

Jan 12, 2023

Study Type

OBSERVATIONAL

Conditions

Acute Renal Injury

Summary

Implementation of an evidence-based and best practices acute RRT pathway aiming to decrease acute RRT program and healthcare systems costs while improving important patient-reported outcomes.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying KPI reports and Prescriber reports for people with acute renal injury. The study is currently recruiting participants at 15 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERKPI reports

Quarterly

OTHERPrescriber reports

Individualized prescriber reports for acute RRT initiation patterns along with targeted education to ensure that align with best evidence-based practices

Locations(15)

Peter Lougheed Centre

Calgary, Alberta, Canada

Foothills Medical Centre

Calgary, Alberta, Canada

Rockyview General Hospital

Calgary, Alberta, Canada

Alberta Children's Hospital

Calgary, Alberta, Canada

South Health Campus

Calgary, Alberta, Canada

Royal Alexandra Hospital

Edmonton, Alberta, Canada

Misericordia Community Hospital

Edmonton, Alberta, Canada

Manzankowski Alberta Heart Institute

Edmonton, Alberta, Canada

Stollery Children's Hospital

Edmonton, Alberta, Canada

University of Alberta Hospital

Edmonton, Alberta, Canada

Grey Nuns Community Hospital

Edmonton, Alberta, Canada

Grande Prairie Regional Hospital

Grande Prairie, Alberta, Canada

Chinook Regional Hospital

Lethbridge, Alberta, Canada

Red Deer Regional Hospital Centre

Red Deer, Alberta, Canada

Sturgeon Community Hospital

St. Albert, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05186636

Related Trials

Kidney Precision Medicine Project

NCT0433470713 locations

Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation

NCT051452832 locations